Skip to main content
. Author manuscript; available in PMC: 2013 Sep 18.
Published in final edited form as: Biomed Pharmacother. 2010 Nov 4;64(10):723–732. doi: 10.1016/j.biopha.2010.10.001

Fig. 6.

Fig. 6

In vivo application of PEHMB does not result in the recruitment of CD45-positive immune cells to the cervical epithelium. Tissues harvested from Swiss Webster mice that were (A and B) mock exposed or exposed to (C and D) N-9, (E and F) PHMB, or (G and H) PEHMB for 2 h were reacted with a monoclonal rat antimouse antibody specific to CD45, which identifies all cells of hematopoietic origin (except erythrocytes). Representative fields from the cervical epithelium of each treatment group are shown. H&E: hematoxylin and eosin.